SARS-CoV-2 IgM/IgG Antibody

Tsanangudzo Pfupi

Iyi kit inoitirwa in vitro qualitative yekuona yeSARS-CoV-2 IgG antibody mumasampuli emunhu e serum/plasma, ropa re venous uye ropa remunwe, kusanganisira SARS-CoV-2 IgG antibody muvanhu vane utachiona uye vaccine.

Tumira email kwatiri

Product Detail

Product Tags

Product name

HWTS-RT090-SARS-CoV-2 IgM/IgG Antibody Detection Kit (Colloidal goridhe nzira)

Chitupa

Epidemiology

Coronavirus Chirwere 2019 (COVID-19), ipneumonia inokonzerwa nehutachiona hwekoronavirus inonzi Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2). SARS-CoV-2 inoona coronavirus mu β genus uye munhu anowanzo batwa neSARS-CoV-2. Iwo makuru masosi ehutachiona ndivo vakasimbiswa COVID-19 varwere uye asymptomatic mutakuri weSARS-CoV-2. Zvichienderana neazvino epidemiological kuferefeta, iyo incubation nguva ndeye 1-14 mazuva, kazhinji 3-7 mazuva. Zvinonyanya kuratidza fivha, chikosoro chakaoma, uye kuneta. Nhamba shoma yevarwere inoperekedzwa nemhino yemhino, runny mhino, kurwadziwa kwehuro, myalgia uye manyoka.

Technical Parameters

Nzvimbo yechinangwa	SARS-CoV-2 IgM/IgG Antibody
Kuchengetedza tembiricha	4℃-30℃
Muenzaniso mhando	Serum yevanhu, plasma, venous ropa uye nemunwe ropa
Sherufu hupenyu	24 mwedzi
Zviridzwa zvebetsero	Hazvidiwi
Extra Consumables	Hazvidiwi
Nguva yekuonekwa	10-15 mins
Zvakananga	Iko hakuna kuchinjika-kusangana nehutachiona, senge Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel furuwenza A (H1N1) furuwenza hutachiona (2009 HCov-2009, HCoV-HKU1, HCOV-NL63, H1N1, novel furuwenza A (H1N1) hutachiona hwefuruwenza (2009 HCov-2, 3 hutachiona hweH 2009) H5N1, H7N9, furuwenza B virus Yamagata, Victoria, kufema syncytial virus A uye B, parainfluenza virus type 1,2,3, Rhinovirus A, B, C, adenovirus type 1,2,3,4,5,7,55.